|Articles|February 12, 2014

Pharm Exec Global Digest—Sales & Marketing Special

In the latest issue of PEGD: Face-to-Face Meetings in the Digital Age; the US Rx Rep in the Obamacare Era; the Future of the iPad - And more

Read the Pharm Exec Global Digest Sales & Marketing Special here

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe Now!

Related Content

Bringing Huntington’s Story to the Public: Q&A with Heather DeMyers

ByMike Hollan

January 30th 2026

Parental Control: Why Pharma’s Strongest Asset May Be Its Parent Brand

ByHugo Hensley

January 5th 2026

Actionable Insights at the Point of Care: A New Era in Provider Engagement

ByDoug Besch

December 10th 2025

Will Pharma’s Direct-to-Patient Push Disintermediate Wholesalers?

ByThani Jambulingam, PhD

November 7th 2025

Deb Nevins is the Chief Marketing & Strategy Officer at POCN Group. POCN Group, an IQVIA business, is the life-sciences engagement division of POCN.

In Obesity Care, NPs and PAs Are the Influencers Marketers Can’t Ignore

ByDeb Nevins

November 7th 2025

Pharm Exec Global Digest—Sales & Marketing Special

Newsletter

Related Content

Bringing Huntington’s Story to the Public: Q&A with Heather DeMyers

Parental Control: Why Pharma’s Strongest Asset May Be Its Parent Brand

Actionable Insights at the Point of Care: A New Era in Provider Engagement

Will Pharma’s Direct-to-Patient Push Disintermediate Wholesalers?

In Obesity Care, NPs and PAs Are the Influencers Marketers Can’t Ignore

Trending on PharmExec

Novo Nordisk Releases 2025 Financial Report and 2026 Sales and Operations Profit Outlook

Eli Lilly Announces New $3.5 Billion Manufacturing Facility in Pennsylvania

Novartis’ Q4 Recap Shows Signs of Looming Patent Cliff

FDA Rejects AstraZeneca’s Application for Subcutaneous Indication of Saphnelo

From OR to Office: How Workflow Change and AI Are Reshaping MedTech Adoption